Prof. Dr. Dagmar Fischer

Funktionen

• Lehrstuhlinhaberin für Pharmazeutische Technologie
• Stellvertretende Direktorin des Jena Center for Soft Matter (JCSM)

Forschungsgebiete

• Natural and Synthetic Polymers as Drug Delivery Systems
• Bacterial Nanocellulose as Drug Delivery System
• Nanosafety, Biocompatibility and Risk Management of Materials; Alternatives to Animal Experiments (3R Concepts)
• NanoBel InflammAging

Publikationen (ausgewählte 5 aktuelle)

1. T. Bellmann, J. Thamm, U. Beekmann, D. Kralisch, D. Fischer, In situ formation of polymer microparticles in bacterial nanocellulose using alternative and sustainable solvents to incorporate lipophilic drugs, Pharmaceutics, 15 (2023) 559. DOI: 10.3390/ pharmaceutics15020559
2. A. Czapka, C. Grune, P. Schädel, V. Bachmann, K. Scheuer, M. Dirauf, C. Weber, A.L. Skaltsounis, K.D. Jandt, U.S. Schubert, D. Fischer, O. Werz. Drug delivery of 6-bromoindirubin-3’-glycerol-oxime ether employing poly(d,l-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents, J. Nanobiotechnology, 20 (2022) 1-21. DOI: 10.1186/s12951-021-01179-7
3. M. Rabel, P. Warncke, M. Thürmer, C. Grüttner, C. Bergemann, H.D. Kurland, F.A. Müller, A. Koeberle, D. Fischer, The differences of the impact of a lipid and protein corona on the colloidal stability, toxicity, and degradation behavior of iron oxide nanoparticles. Nanoscale 13 (2021) 9415-9435. DOI: 10.1039/D0NR09053K
4. C. Grune,C. Zens,A. Czapka,K. Scheuer,J. Thamm, S. Hoeppener, K.D. Jandt,O. Werz,U. Neugebauer, D. Fischer, Sustainable preparation of anti-inflammatory atorvastatin PLGA nanoparticles, Int. J. Pharmaceutics, 599 (2021) 120404. DOI: 10.1016/j.ijpharm.2021.120404
5. F. Hack, C. Cokca, S. Städter, J. Hülsmann, K. Peneva, D. Fischer, Indole, Phenyl, and Phenol Groups: The Role of the Comonomer on Gene Delivery in Guanidinium Containing Methacrylamide Terpolymers, Macromolecular Rapid Communications 42 (2021) 5920. DOI: 10.1002/marc.202170025